Gentibio, Inc
Clinical trials sponsored by Gentibio, Inc, explained in plain language.
-
Could a single dose of engineered cells help control type 1 diabetes?
Disease control Recruiting nowThis early-stage study tests a new cell therapy called GNTI-122 in 16 adults recently diagnosed with type 1 diabetes. The therapy is made from the participant's own blood cells and aims to help the body better manage blood sugar by preserving insulin-making cells. The main goal i…
Phase: PHASE1 • Sponsor: GentiBio, Inc • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New study maps gene patterns in recent type 1 diabetes cases
Knowledge-focused Recruiting nowThis study is for adults aged 18 to 55 who were diagnosed with type 1 diabetes within the last 6 months. Researchers will test a blood sample to see if participants have a specific genetic marker called HLA-DRB1*04:01. The goal is to understand how common this marker is in differ…
Sponsor: GentiBio, Inc • Aim: Knowledge-focused
Last updated May 17, 2026 05:42 UTC